HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of antilipopolysaccharide (anti-LPS) antibodies in the management of septic shock. A preliminary report.

Abstract
Twenty-two patients who were in severe sepsis or in septic shock, some with multiple-system failure, were treated with antilipopolysaccharide (anti-endotoxin) antibodies, given in the form of gammaglobulin or as antibody-rich freeze-dried plasma. Twenty patients responded to the treatment either completely or temporarily. The beneficial effect and the physiological aspects of this treatment as opposed to other suggested treatments in the management of septic shock are discussed.
AuthorsS L Gaffin, E Lachman
JournalSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde (S Afr Med J) Vol. 65 Issue 5 Pg. 158-61 (Feb 04 1984) ISSN: 0256-9574 [Print] South Africa
PMID6695272 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Lipopolysaccharides
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies (administration & dosage)
  • Child, Preschool
  • Humans
  • Lipopolysaccharides (immunology)
  • Middle Aged
  • Shock, Septic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: